VIC Team

VIC Team

Recent Posts

Nob Hill Therapeutics to Present at Partnership Opportunities in Drug Delivery (PODD) Conference

Nob Hill Therapeutics' Executive Chairman Paul Atkins will be presenting at the Partnership Opportunities in Drug Delivery (PODD) conference during the DryNeb – Advancing Pulmonary Drug Delivery session on Friday,...

VIC Fellows Spotlight: Secondra Holmes, PhD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovation from global sources. We are pleased to highlight the...

Neurexis Therapeutics Awarded NIH Phase I SBIR Grant to Accelerate IND-Enabling Studies of Neuroprotective Therapeutic

A promising approach for preventing cognitive and behavioral impairment following ischemic events such as cardiac arrest and stroke. Aurora, CO - Neurexis Therapeutics, Incorporated, announces it has been awarded a...

Nob Hill Therapeutics Selected as a Finalist for RESI Innovator’s Pitch Challenge

Nob Hill Therapeutics was selected as a finalist in the Redefining Early Stage Investments (RESI) Innovator’s Pitch Challenge (IPC). An opportunity for early-stage companies to gain exposure to conference attendees,...

CardioWise Named Quarterfinalists at the UCSF Health Awards

The University of California San Francisco (UCSF) Health Awards has selected CardioWise, Inc. as a Quarterfinalist in the Hospital Diagnostics Category. The awards showcase the health tech industry, showcasing the best...

Solaris Vaccines Formed to Develop and Commercialize a Rapid, Flexible Vaccine Manufacturing Platform

New company advances novel vaccines to better fight COVID-19 and other pathogens FORT COLLINS, CO - VIC Technology Venture Development, LLC (VIC), announced today the formation of Colorado-based Solaris Vaccines, Inc.,...

VIC Fellows Spotlight: Evan Goldberg, PhD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovation from global sources. We are pleased to highlight the...

VIC 2021 Mid-Year Update Executive Summary

In the first half of 2021, we have seen a return to more normal operations across VIC and our portfolio of companies. Progress across VIC and our portfolio of companies in 2021 H1 has been strong. Click Here to download...

VIC Technology Venture Development Announces New Board of Directors Appointment

VIC adds another esteemed health care veteran to Board. Fayetteville, AR - VIC Technology Venture Development has announced the appointment of Ajay Gupta, who brings 30 years of executive healthcare experience, to its...

Inside Blackstone LaunchPad at UT Southwestern Medical Center with Brad Phelan

Brad Phelan serves as the Director of Technology Commercialization and Director of Blackstone LaunchPad for UTSW. We recently had a chance to discuss the overall topic of UTSW’s role in the rise of North Texas as the...

FEATURED RESOURCES

Updates
VIC Tech Announces New Class of Fellows
Insight
Our Life Science and Healthcare Future
White Paper
Portfolio Diversification in Times of Market Volatility
Interview
Inside the Office of Technology Commercialization at the University of Kentucky with Holly Clark, PhD, Senior Commercialization Manager
Insight
Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio
White Paper
Investing in Medical Devices & Diagnostics – Industry Trends and Investor Activity
News
Nob Hill Therapeutics Secures Series A Funding to Advance Breakthrough Respiratory Technologies
Interview
VIC Fellows Spotlight: Matthew Leming, PhD
From The Corner Office
From the Corner Office: Zebra Analytix